Type
Hormone Testing
Biomarkers
19
Duration
10 min
A nineteen-biomarker hormone panel designed for women over 40, covering the full reproductive axis alongside thyroid, adrenal, and metabolic markers relevant to perimenopause and menopause. Provides a detailed hormonal snapshot to help contextualise symptoms that commonly emerge during this transitional period.
The hormonal landscape shifts significantly for women approaching and entering perimenopause, typically between ages 40 and 55. Oestrogen and progesterone fluctuations can produce a wide range of symptoms — sleep disruption, mood changes, hot flashes, joint discomfort, weight redistribution, and cognitive fog — that are frequently attributed to stress or ageing rather than investigated hormonally. This 19-marker panel captures the full picture: reproductive hormones (oestradiol, progesterone, FSH, LH, AMH), androgens (testosterone, DHEAS, SHBG, FAI), thyroid function (TSH and additional thyroid markers), adrenal output (cortisol), and metabolic indicators. Anti-Müllerian hormone (AMH) provides information about ovarian reserve, while the FSH-to-LH ratio helps characterise where a woman sits on the perimenopause continuum. The panel is broader than the standard female hormone check to capture the interplay between declining reproductive hormones and compensatory changes in thyroid, adrenal, and metabolic function that commonly accompany this transition. Results are delivered digitally within one to three business days, providing a data-driven foundation for conversations with a gynaecologist, endocrinologist, or integrative medicine practitioner about symptom management and monitoring strategies.
Key Details
- Biomarkers
- 19
- Focus
- Perimenopause / menopause
- Duration
- ~10 min
- Accreditation
- DAkkS / ISO 15189
Who Is This For?
Women 40+, perimenopause symptoms, menopause transition, hormonal baseline before HRT discussions
